UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041854
Receipt number R000047778
Scientific Title Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients
Date of disclosure of the study information 2020/09/21
Last modified on 2023/04/09 19:21:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients

Acronym

Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients

Scientific Title

Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients

Scientific Title:Acronym

Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients

Region

Japan


Condition

Condition

Trauma

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish a treatment for trauma patients by early TXA administration, we will administer TXA to trauma patients transported by the doctor car or the helicopter in prehospital settings, and confirm the efficacy and safety of TXA administration based on the clinical course and outcome of the patients. In addition, we will examine the efficacy of TXA administration in prehospital settings based on the changes in coagulation fibrinolytic parameters and elucidate the pathogenesis of coagulation fibrinolytic disorders associated with trauma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mortality at 28 days

Key secondary outcomes

mRS at 3 months, volume of transfusion, coagulation fibrinolytic parameters (prothrombin time (PT), activated partial thromboplastin time (aPTT), Fibrinogen, thrombin-antithrombin complex (TAT), FDP, D-dimer, alpha 2 plasmin inhibitor (alpha 2-PI), plasmin-alpha 2 plasmin inhibitor complex (PIC), plasminogen activator inhibitor 1 (PAI-1), t-PA-PAI-1 complex)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administer 1 g of TXA intravenously in prehospital settings.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients over the age of 18 years.
2. Trauma patients who are transported by the doctor car or the helicopter to Nippon Medical School Hospital, Nippon Medical School Musashikosugi Hospital, Nippon Medical School Tama-Nagayama Hospital, or Nippon Medical School Chiba Hokuso Hospital.
3. Patients who are able to receive TXA in prehospital settings within 3 hours of the injury.

Key exclusion criteria

1. Patients with a history of hypersensitivity to TXA
2. Patients with diseases (liver disease, hematological diseases, infections, malignant neoplasms, pregnancy) that affect the coagulation fibrinolytic parameters.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Ryuta
Middle name
Last name Nakae

Organization

Nippon Medical School

Division name

Department of Emergency and Critical Care Medicine

Zip code

113-8603

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

nakae@nms.ac.jp


Public contact

Name of contact person

1st name Ryuta
Middle name
Last name Nakae

Organization

Nippon Medical School

Division name

Department of Emergency and Critical Care Medicine

Zip code

113-8603

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Homepage URL


Email

nakae@nms.ac.jp


Sponsor or person

Institute

Department of Emergency and Critical Care Medicine, Nippon Medical School

Institute

Department

Personal name



Funding Source

Organization

KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Nippon Medical School Hospital

Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

Tel

03-3822-2131

Email

03-3822-2131


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本医科大学付属病院 高度救命救急センター、日本医科大学武蔵小杉病院 救命救急センター、日本医科大学多摩永山病院 救命救急センター、日本医科大学千葉北総病院 救命救急センター


Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

34

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 01 Day

Date of IRB

2019 Year 09 Month 19 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 09 Month 21 Day

Last modified on

2023 Year 04 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047778


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name